TRACY BIAGIOLI: Open Payments
NPI 1780215566 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 63 payments from 30 companies in 2025. Trend: 2023 $782 · 2024 $914 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $270 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Janssen Biotech, Inc. | 4 | $84 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Celgene Corporation | 2 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $68 |
| ARRAY BIOPHARMA INC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Legend Biotech USA Inc. | 1 | $42 |
Products named: IBRANCE, ENHERTU, REBLOZYL, OPDIVO, PADCEV, CARVYKTI, Nubeqa, IMFINZI.
Industry payments across FL — which companies pay providers there.
